Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorder

Psychopharmacology

Volumn 213, Issue 2-3, 2011, Pages 547-553

  Murrough, James W ^a   Henry, Shannan ^b   Hu, Jian ^b   Gallezot, Jean Dominique ^c   Planeta Wilson, Beata ^c   Neumaier, John F ^d   Neumeister, Alexander ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Brain imaging; Human subjects; Major depressive disorder; Positron emission tomography; Serotonin; Serotonin1B receptor; Ventral striatum

Indexed keywords

P 943 C 11; RADIOLIGAND; SEROTONIN 1B RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GLOBUS PALLIDUS; HUMAN; MAJOR DEPRESSION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; VENTRAL PALLIDUM;

ADULT; BASAL GANGLIA; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GLOBUS PALLIDUS; HUMANS; MALE; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINONES; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT1B; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; YOUNG ADULT;

EID: 79952489723     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1881-0     Document Type: Article

References (42)

1. aan het Rot M, Mathew SJ, Charney DS (2009) Neurobiological mechanisms in major depressive disorder. CMAJ 180:305-313. doi:10.1503/cmaj.080697
2. American Psychiatric Association. Task Force on DSM-IV (2000) Diagnostic and statistical manual of mental disorders: DSM-IVTR. American Psychiatric Association, Washington
3. Belmaker RH, Agam G (2008) Major depressive disorder. N Engl J Med 358:55-68. doi:10.1056/NEJMra073096
4. Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ (2004) Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry 9:386-392. doi:10.1038/sj.mp.4001401 (Pubitemid 38534699)
5. Brody AL, Olmstead RE, Abrams AL, Costello MR, Khan A, Kozman D, Saxena S, Farahi J, London ED, Mandelkern MA (2009) Effect of a history of major depressive disorder on smoking-induced dopamine release. Biol Psychiatry 66:898-901. doi:10.1016/j.biopsych.2009.06.011
6. Carlezon WA Jr, Thomas MJ (2009) Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 56(Suppl 1):122-132. doi:10.1016/j.neuropharm.2008.06.075
7. Chenu F, David DJ, Leroux-Nicollet I, Le Maitre E, Gardier AM, Bourin M (2008) Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system. J Psychiatry Neurosci 33:541-550
8. Cleare AJ, Murray RM, Sherwood RA, O'Keane V (1998) Abnormal 5-HT1D receptor function in major depression: a neuropharmacological challenge study using sumatriptan. Psychol Med 28:295-300 (Pubitemid 28197545)
9. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C (1999) PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46:1375-1387
10. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C (2007) Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 34:865-877. doi:10.1016/j.nucmedbio.2007.06. 008 (Pubitemid 47505401)
11. Epstein J, Pan H, Kocsis JH, Yang Y, Butler T, Chusid J, Hochberg H, Murrough J, Strohmayer E, Stern E, Silbersweig DA (2006) Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. Am J Psychiatry 163:1784-1790. doi:10.1176/appi.ajp.163.10.1784 (Pubitemid 44522488)
12. First MB, Spitzer RL, Gibbon M, Williams JBW (1995) Structured Clinical Interview for DSM-IV Axis Disorders (SCID). New York State Psychiatric Institute, Biometrics Research, New York
13. Gallezot JD, Nabulsi N, Neumeister A, Planeta-Wilson B, Williams WA, Singhal T, Kim S, Maguire RP, McCarthy T, Frost JJ, Huang Y, Ding YS, Carson RE (2010) Kinetic modeling of the serotonin 5-HT(1B) receptor radioligand [(11)C]P943 in humans. J Cereb Blood Flow Metab 30:196-210. doi:10.1038/jcbfm. 2009.195
14. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50-55
15. Hannon J, Hoyer D (2008) Molecular biology of 5-HT receptors. Behav Brain Res 195:198-213. doi:10.1016/j.bbr.2008.03.020
16. Hasler G, Fromm S, Carlson PJ, Luckenbaugh DA, Waldeck T, Geraci M, Roiser JP, Neumeister A, Meyers N, Charney DS, Drevets WC (2008) Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Arch Gen Psychiatry 65:521-531. doi:10.1001/archpsyc.65.5.521 (Pubitemid 351645048)
17. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom Test for nicotine dependence: a revision of the Fagerstrom Tolerance questionnaire. Br J Addict 86:1119-1127
18. Heninger GR, Charney DS, Sternberg DE (1984) Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Arch Gen Psychiatry 41:398-402
19. Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533-554 (Pubitemid 34219205)
20. Hu J, Henry S, Gallezot JD, Ropchan J, Neumaier JF, Potenza MN, Sinha R, Krystal JH, Huang Y, Ding YS, Carson RE, Neumeister A (2010) Serotonin 1B receptor imaging in alcohol dependence. Biol Psychiatry. doi:10.1016/j.biopsych. 2009.12.028
21. Ichise M, Liow JS, Lu JQ, Takano A, Model K, Toyama H, Suhara T, Suzuki K, Innis RB, Carson RE (2003) Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23:1096-1112. doi:10.1097/01.WCB.0000085441.37552.CA (Pubitemid 37082435)
22. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533-1539. doi:10.1038/sj.jcbfm. 9600493 (Pubitemid 47301451)
23. Jans LA, Riedel WJ, Markus CR, Blokland A (2007) Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. Mol Psychiatry 12:522-543. doi:10.1038/sj.mp.4001920 (Pubitemid 46816766)
24. Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894-902. doi:10.1038/nature07455
25. Maxwell ME (1992) Family Interview for Genetic Studies (FIGS): Manual For FIGS. Clinical Neurogenetics Branch, Intramural Research Program, National Institute of Mental Health, Bethesda, MD
26. Meyer JH, McNeely HE, Sagrati S, Boovariwala A, Martin K, Verhoeff NP, Wilson AA, Houle S (2006) Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study. Am J Psychiatry 163:1594-1602. doi:10.1176/appi.ajp.163.9.1594 (Pubitemid 44465761)
27. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389 (Pubitemid 9136500)
28. Nabulsi N, Huang Y, Weinzimmer D, Ropchan J, Frost JJ, McCarthy T, Carson RE, Ding YS (2010) High-resolution imaging of brain 5-HT 1B receptors in the rhesus monkey using [11C]P943. Nucl Med Biol 37:205-214. doi:10.1016/j. nucmedbio.2009.10.007
29. Nestler EJ, Carlezon WA Jr (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151-1159. doi:10.1016/j.biopsych.2005.09.018 (Pubitemid 44192421)
30. Neumeister A, Nugent AC, Waldeck T, Geraci M, Schwarz M, Bonne O, Bain EE, Luckenbaugh DA, Herscovitch P, Charney DS, Drevets WC (2004) Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry 61:765-773. doi:10.1001/archpsyc.61.8.765 (Pubitemid 39031116)
31. Neumeister A, Hu XZ, Luckenbaugh DA, Schwarz M, Nugent AC, Bonne O, Herscovitch P, Goldman D, Drevets WC, Charney DS (2006) Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry 63:978-986. doi:10.1001/archpsyc.63.9.978 (Pubitemid 44330456)
32. Pauwels PJ (1997) 5-HT 1B/D receptor antagonists. Gen Pharmacol 29:293-303
33. Pizzagalli DA, Holmes AJ, Dillon DG, Goetz EL, Birk JL, Bogdan R, Dougherty DD, Iosifescu DV, Rauch SL, Fava M (2009) Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry 166:702-710. doi:10.1176/appi.ajp.2008.08081201
34. Ruf BM, Bhagwagar Z (2009) The 5-HT(1B) receptor: a novel target for the pathophysiology of depression. Curr Drug Targets 10:1118-1138
35. Sari Y (2004) Serotonin1B receptors: from protein to physiological function and behavior. Neurosci Biobehav Rev 28:565-582. doi:10.1016/j. neubiorev.2004.08.008
36. Savitz J, Lucki I, Drevets WC (2009) 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol 88:17-31. doi:10.1016/j.pneurobio.2009.01. 009
37. Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M, Vaugeois JM, Nomikos GG, Greengard P (2006) Alterations in 5-HT1B receptor function by p11 in depressionlike states. Science 311:77-80. doi:10.1126/science.1117571 (Pubitemid 43063061)
38. Tatarczynska E, Klodzinska A, Stachowicz K, Chojnacka-Wojcik E (2004) Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression. Behav Pharmacol 15:523-534 (Pubitemid 40075900)
39. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273-289. doi:10.1006/nimg.2001.0978 (Pubitemid 34852226)
40. Varnas K, Hurd YL, Hall H (2005) Regional expression of 5-HT1B receptor mRNA in the human brain. Synapse 56:21-28. doi:10.1002/syn.20128 (Pubitemid 40322360)
41. Whale R, Clifford EM, Bhagwagar Z, Cowen PJ (2001) Decreased sensitivity of 5-HT(1D) receptors in melancholic depression. Br J Psychiatry 178:454-457 (Pubitemid 32436812)
42. Yan QS, Yan SE (2001) Activation of 5-HT(1B/1D) receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Eur J Pharmacol 418:55-64